Patients' perceptions of well-being using a guided self-management plan in asthma

作者: R. Buhl , D. Price

DOI: 10.1111/J.1368-504X.2004.00262.X

关键词:

摘要: Summary Asthma can place considerable restrictions on the health-related quality of life asthma patients and their families; this burden may be greatest when symptoms are not adequately controlled. The Symbicort® Adjustable Maintenance Dosing Programme, consisting studies from several different countries, compared a guided self-management plan that allows adjustable maintenance dosing using budesonide/formoterol in single inhaler (Symbicort) with fixed dosing. Quality was assessed three asthma-specific generic questionnaires. Clinically relevant improvements mean scores were observed beginning to end 1-month run-in, which maintained or further improved during randomised treatment both groups. A modified patient enablement instrument also used UK study assess patients' feelings control towards asthma. showed significantly (p < 0.05) greater These outcomes achieved less drug usage,

参考文章(39)
M Maxwell, J G Howie, D J Heaney, Measuring quality in general practice. Pilot study of a needs, process and outcome measure. Occasional paper (Royal College of General Practitioners). ,(1997)
M.G. Sawyer, N. Spurrier, L. Whaites, D. Kennedy, A.J. Martin, P. Baghurst, The relationship between asthma severity, family functioning and the health-related quality of life of children with asthma. Quality of Life Research. ,vol. 9, pp. 1105- 1115 ,(2000) , 10.1023/A:1016655511879
Guy Vandenhoven, Rudy Peche, Alain Michils, J. A. Versbroecken, SURF Study: real life effectiveness of budesonide/formoterol (B/F) adjustable maintenance dosing ,(2003)
John E. Ware Jr., D. A. Buchner, A. E. Singer, J. P. Kemp, K. B. Nolop, T. F. Goss, The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults Quality of Life Research. ,vol. 7, pp. 235- 244 ,(1998) , 10.1023/A:1024946316424
L.M. Fabbri, L.P. Boulet, P. Kardos, C. Vogelmeier, The asthma management gap – why current treatment strategies can fail to provide optimal asthma control International Journal of Clinical Practice. ,vol. 58, pp. 1- 8 ,(2004) , 10.1111/J.1368-504X.2004.00259.X
J.M. Fitzgerald, P. Olsson, A. Michils, Adjustable maintenance dosing with budesonide/formoterol in a single inhaler: efficacy and safety International Journal of Clinical Practice. ,vol. 58, pp. 18- 25 ,(2004) , 10.1111/J.1368-504X.2004.00261.X
P.W. Ind, B. Ställberg, S.N. Willich, Adjustable maintenance dosing with budesonide/formoterol (Symbicort®) reduces treatment costs in asthma International Journal of Clinical Practice. ,vol. 58, pp. 33- 41 ,(2004) , 10.1111/J.1368-504X.2004.00263.X
Bérubé D, Becker A, Boulet Lp, Ernst P, Beveridge R, Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. Canadian Medical Association Journal. ,vol. 161, ,(1999)
Guy B. Marks, Stewart M. Dunn, Ann J. Woolcock, An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. Journal of Clinical Epidemiology. ,vol. 46, pp. 1103- 1111 ,(1993) , 10.1016/0895-4356(93)90109-E